FOR IMMEDIATE RELEASE
September 28, 2011
Contact: Donna Krupa
Office: (301) 634-7209
dkrupa@the-aps.org
@Phyziochick
Gender Matters in Heart Health
Selected Highlights from Conference on Physiology of Cardiovascular Disease: Gender Disparities
Bethesda, Md. (Sept. 28, 2011) – Women generally have a lower risk of developing cardiovascular disease (CVD) than men for most of their adult lives, with lower rates of high blood pressure and a tendency toward higher levels of HDL (“good”) cholesterol and lower levels of LDL (“bad”) cholesterol. Then comes the great equalizer: menopause. Post-menopausal women develop higher blood pressure at a greater rate than men and their cholesterol levels tend to worsen, even with no significant changes in diet or physical activity. As a result, women’s risk of CVD quickly catches up to men’s. Yet certain female-only conditions, such as polycystic ovary syndrome (PCOS) and pre-eclampsia, can raise a woman’s risk of CVD to a level on par with a man’s long before she reaches menopause.
That women’s CVD risk increases with conditions that affect their hormonal status suggests that sex hormones play a role in heart health. Experts will explore how both male and female sex hormones affect CVD risk at the Physiology of Cardiovascular Disease: Gender Disparities conference, October 12–14 at the University of Mississippi in Jackson. The conference is hosted by the American Physiological Society with additional support from the American Heart Association.
Below is an overview of the meeting, which will coincide with the grand opening of the Women’s Health Research Center at the university’s medical center.
Thursday, October 13
Symposia I: Aging and CVD
Speakers will cover diabetes and the metabolic syndrome in perimenopausal women, provide an update from the Multi-Ethnic Study of Atherosclerosis trial with respect to early menopause and CVD, and present research on cardiovascular remodeling.
Symposia II: Gender Disparities in Renal Disease
Experts will discuss sex differences in renal injury, podocytes in the urine as an early predictive marker of pre-eclampsia, and the role of androgens in renal disease.
Symposia III: Diabetes, Obesity and Cardiovascular Disease
Researchers will explain the pathophysiology of high blood pressure in obesity and the metabolic syndrome, present research involving the use of pancreatic peptides for the control of glucose homeostasis and appetite, and provide insights into the cardiovascular benefits of exenatide.
Symposia IV: Neuro Mechanisms and Depression in Cardiovascular Disease
Experts will cover the role of sex steroids in baroreflex control and baroreflexes in pregnancy, sex differences in depression and how depression exacerbates CVD, and why men and women respond differently after a stroke.
Friday, October 14
Symposia V: Gender Disparities in Cardiology
With an emphasis on women’s needs, speakers will discuss ischemic heart disease, angina, and how pregnancy history predicts CVD in the future with aging.
Symposia VI: Cardiovascular Disease and Inflammation
Researchers will discuss immune mechanisms in CVD, the role of sex hormones in immune system function, and sex differences in inflammatory mediators.
Symposia VII: Gender Differences in Vascular Function
Experts will explain cerebral vascular function in pregnancy and pre-eclampsia, how sex hormones differentially affect endothelial function, and how estrogen signaling affects inflammatory responses.
Symposia VIII: Cardiovascular Disease and Fertility
Speakers will discuss CVD and PCOS, angiotensin 1 receptor autoantibodies in pre-eclampsia, and how angiogenic factors contribute to the hypertension in women with pre-eclampsia.
Additional Information
The full program is available online at the APS website. Press releases about new study findings will be available on the APS press page during the conference. The meeting is chaired by Dr. Jane Reckelhoff, Professor of Physiology and Biophysics Director, Women's Health Research at the University of Mississippi. Come to Jackson and enjoy Southern Hospitality and great research!
NOTE TO EDITORS: The Physiology of Cardiovascular Disease: Gender Disparities conference will be held October 12–14 at the University of Mississippi in Jackson. The press is invited to attend. For additional information, please contact Donna Krupa at 301.634.7209 or dkrupa@the-aps.org.
***
Physiology is the study of how molecules, cells, tissues and organs function to create health or disease. The American Physiological Society has been an integral part of the discovery process since it was established in 1887. To keep up with the science, follow @Phyziochick on Twitter.
In Heart Disease, Men and Women are Different
Released August 15, 2011 - When it comes to heart disease, men and women are different. Our October 2011 conference focuses on the role of gender in cardiovascular disease, a disease that kills more women than breast cancer.
Cardio Exercise Benefits In Male Vs. Female Hearts
Released August 8, 2007 - While cardiovascular disease occurs in both men and women, it does not affect them in the same way. Risk factors and protective factors for heart diseases are likewise unequal. The molecular mechanisms responsible for these differences are so far unknown, but some believe it is due to chromosomal linked genes or sexual hormones such as estrogen and testosterone. While the mechanisms behind the differences are unknown, the physiological differences are clear. A new study examining chronic exercise in male and female mice finds that moderate long-term exercise provokes a sex-dependent cardiac adaptation that is different for females versus males. The findings may eventually help improve treatment strategies for women and men with heart disease.
Gender Differences In Renal And Other Genes Contribute To BP
Released August 8, 2007 - In a new study, researchers examined the differential contribution of genetic factors involved in regulating blood pressure based on samples drawn from a large community. They found significant differences in genetic contributors to blood pressure in males versus females.